INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,231 | -9.9% | 28,871 | +3.4% | 0.00% | – |
| Q2 2023 | $12,463 | -46.8% | 27,913 | -2.3% | 0.00% | – |
| Q1 2023 | $23,422 | -45.9% | 28,563 | +3.0% | 0.00% | – |
| Q4 2022 | $43,273 | -9.8% | 27,739 | -0.0% | 0.00% | – |
| Q3 2022 | $48,000 | -7.7% | 27,752 | -7.3% | 0.00% | – |
| Q2 2022 | $52,000 | -31.6% | 29,923 | +8.1% | 0.00% | – |
| Q1 2022 | $76,000 | -46.5% | 27,669 | -2.8% | 0.00% | – |
| Q4 2021 | $142,000 | -32.4% | 28,459 | -3.0% | 0.00% | – |
| Q3 2021 | $210,000 | -25.8% | 29,345 | -3.9% | 0.00% | – |
| Q2 2021 | $283,000 | -3.7% | 30,526 | -3.7% | 0.00% | – |
| Q1 2021 | $294,000 | -16.0% | 31,709 | -19.8% | 0.00% | – |
| Q4 2020 | $350,000 | -37.7% | 39,523 | -18.4% | 0.00% | -100.0% |
| Q3 2020 | $562,000 | -42.3% | 48,423 | +34.0% | 0.00% | 0.0% |
| Q2 2020 | $974,000 | +191.6% | 36,148 | -19.6% | 0.00% | – |
| Q1 2020 | $334,000 | +171.5% | 44,950 | +21.0% | 0.00% | – |
| Q4 2019 | $123,000 | +261.8% | 37,149 | +126.3% | 0.00% | – |
| Q3 2019 | $34,000 | – | 16,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|